e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Clinical assessment of airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint
L. Marín Barrera, C. López Ramírez, J. L. López-Campos, C. Calero Acuña, A. Fernández-Villar, C. Represas Represas, A. Priegue Carrera, R. Casamor (Sevilla, Madrid, Vigo, Barcelona, Spain)
Source:
International Congress 2014 – Clinical assessment of airway diseases
Session:
Clinical assessment of airway diseases
Session type:
Thematic Poster Session
Number:
4019
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Marín Barrera, C. López Ramírez, J. L. López-Campos, C. Calero Acuña, A. Fernández-Villar, C. Represas Represas, A. Priegue Carrera, R. Casamor (Sevilla, Madrid, Vigo, Barcelona, Spain). Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint. Eur Respir J 2014; 44: Suppl. 58, 4019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Frequency of depression in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Chronic obstructive pulmonary disease (COPD) and alterations of hemogram
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Diabetes mellitus and obstructive pulmonary disease. Is there an association?
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014
Clinical factors linked with coronary artery disease in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Peripheral neuropathy in chronic obstructive pulmonary disease
Source: International Congress 2014 – Comorbidities
Year: 2014
Nutritional status in chronic obstructive pulmonary disease
Source: International Congress 2014 – Comorbidities
Year: 2014
Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
The metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Prognostic significance of neutrophil to lymphocyte ratio in chronic obstructive pulmonary disease
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
LATE-BREAKING ABSTRACT: Multidimensional assessment of patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Predictors
Year: 2014
Diabetes and hospitalization for COPD exacerbation
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Chronic obstructive pulmonary disease and comorbidities
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Emphysematous phenotype is an independent predictor for frequent exacerbation of chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014
Severity of airway obstruction in overweight/obese patients with chronic obstructive pulmonary disease(COPD)
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
High prevalence of undiagnosed airflow obstruction in patients with ischaemic heart disease
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014
Prediction of the duration of hospitilization in acute COPD exacerbations: The AECOPD-F score
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept